visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Kolltan Pharmaceuticals, Inc.

    Get Full Access

    Description

    • Kolltan, a privately held clinical-stage company, is focused on advancing a new generation of therapeutics in oncology and other diseases by discovering and developing novel biologic agents designed to modulate the function of receptor tyrosine kinases (RTKs). Kolltan is led by an experienced team of executives and scientists with a deep understanding of RTKs, their ligands, and cellular signaling. Located adjacent to the Yale Medical School in New Haven, Connecticut, Kolltan is working in close collaboration with the laboratory of Kolltan co-founder, Dr. Joseph Schlessinger, as well as the Yale medical and scientific community to bring important medicines to cancer patients and other patients with serious diseases. The Company's R&D pipeline is advancing rapidly, with the first clinical trial initiated in January 2014.
    • location

      Headquarters:300 George Street Suite 530, New Haven, Connecticut, United States

      More
    • Kolltan Pharmaceuticals, Inc. phone

      Phone Number: +1 203-773-3000

    • Kolltan Pharmaceuticals, Inc. website

      Website: https://www.kolltan.com

    • Kolltan Pharmaceuticals, Inc. employees

      Employees:11

    • Kolltan Pharmaceuticals, Inc. revenue

      Revenue:$10 - 50M

    • Kolltan Pharmaceuticals, Inc. legal name

      Legal Name:Kolltan Pharmaceuticals, Inc.

    • Kolltan Pharmaceuticals, Inc.'s Social Media

      Kolltan Pharmaceuticals, Inc. linkedin Kolltan Pharmaceuticals, Inc. twitter
    • done Is this data correct?

    • |  NAICS Code: 424210  |

      Show More
    Person level website identification

    CEO for Kolltan Pharmaceuticals, Inc.

    Carmela Senese

    Executive Administrative To President And Chief Executive Officer; Senior Vice President, Chief Financial And Business Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Colin Callaghan

    Director

    Lauren Waggoner

    Accounting Manager

    Frequently Asked Questions regarding Kolltan Pharmaceuticals, Inc.

    • Where are Kolltan Pharmaceuticals, Inc.'s Headquarters?

      Kolltan Pharmaceuticals, Inc.'s Headquarters are in 300 George Street Suite 530,New Haven,Connecticut,United States

    • What is Kolltan Pharmaceuticals, Inc.'s phone number?

      Kolltan Pharmaceuticals, Inc.'s phone number is +1 203-773-3000

    • What is Kolltan Pharmaceuticals, Inc.'s official website?

      Kolltan Pharmaceuticals, Inc.'s official website is https://www.kolltan.com

    • What is Kolltan Pharmaceuticals, Inc.'s Revenue?

      Kolltan Pharmaceuticals, Inc.'s revenue is $10 - 50M

    • What is Kolltan Pharmaceuticals, Inc.'s NAICS code?

      Kolltan Pharmaceuticals, Inc.'s NAICS code is 424210

    • How many employees are working in Kolltan Pharmaceuticals, Inc.

      Kolltan Pharmaceuticals, Inc. has 11 employees

    • What is Kolltan Pharmaceuticals, Inc.'s Industry?

      Kolltan Pharmaceuticals, Inc. is in the industry of Biotechnology

    • Who is Kolltan Pharmaceuticals, Inc.'s CEO?

      Kolltan Pharmaceuticals, Inc.'s CEO is Carmela Senese

    Company Directory